Thomas Brabletz

13PUBLICATIONS
70CO-AUTHORS
Computational imagingMolecular targetsTumour immunologyPredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 07, 2026
Loss of endothelial ZEB1 enhances neovascularisation during choroidal neovascularisation.

|Nov 18, 2025
The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche.

Laura Wormser, Valerie Fritz, Melanie Kappelmann-Fenzl

|Jul 02, 2025
Macrophages foster anti-tumor immunity by ZEB1-dependent cytotoxic T cell chemoattraction.

Kathrin Fuchs, Elisabetta D'Avanzo, Isabell Armstark

|May 09, 2025
Development and validation of a high-throughput screening pipeline of compound libraries to target EMT.

Sven Jonckheere, Joachim Taminau, Jamie Adams

|Jul 15, 2024
Zeb1 mediates EMT/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition.

Annemarie Schwab, Zhigang Rao, Jie Zhang

|Jun 27, 2024
ZEB1-mediated fibroblast polarization controls inflammation and sensitivity to immunotherapy in colorectal cancer.

Constantin Menche, Harald Schuhwerk, Isabell Armstark

Pageof 3

Frequent Collaborators

10 joint publications

Marc Stemmler

7 joint publications

Simone Brabletz

3 joint publications

Harald Schuhwerk

2 joint publications

Fulvia Ferrazzi